go to medicines.ie homepage
Font Size
Search for:  
select
  Advanced Search

Sanofi Pasteur MSD Limited
Block A, Second Floor, Cookstown Court, Old Belgard Road, Tallaght, Dublin 24,
Telephone: +353 1 468 5600
Fax: +353 1 420 3588
Medical Information Direct Line: +44 (0)1628 587 693
Medical Information e-mail: medinfo@spmsd.com
Medical Information Facsimile: +44 (0)1628 635 072
Patient Information Leaflet last updated on medicines.ie: 16/01/2012
PIL GARDASIL

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 16/01/2012 and displayed until Current
Reasons for adding or updating:
  • Change to side-effects
Updated on 16/08/2011 and displayed until 16/01/2012
Reasons for adding or updating:
  • Change to side-effects
  • Change to information about driving or using machinery
  • Change to how the medicine works
  • Changes to therapeutic indications
Updated on 02/09/2010 and displayed until 16/08/2011
Reasons for adding or updating:
  • Change to, or new use for medicine
Updated on 10/06/2010 and displayed until 02/09/2010
Reasons for adding or updating:
  • Change to side-effects
Updated on 28/09/2009 and displayed until 10/06/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
Updated on 04/08/2009 and displayed until 28/09/2009
Reasons for adding or updating:
  • Change to side-effects
  • Change to drug interactions
  • Change to dosage and administration
Updated on 30/06/2009 and displayed until 04/08/2009
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 19/06/2009 and displayed until 30/06/2009
Reasons for adding or updating:
  • Improved electronic presentation
Updated on 18/06/2009 and displayed until 19/06/2009
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 11/03/2009 and displayed until 18/06/2009
Reasons for adding or updating:
  • Improved electronic presentation
Updated on 10/03/2009 and displayed until 11/03/2009
Reasons for adding or updating:
  • Change to side-effects
Updated on 05/12/2008 and displayed until 10/03/2009
Reasons for adding or updating:
  • Change to side-effects
  • Improved electronic presentation
  • Addition of marketing authorisation holder
  • Change to date of revision
Updated on 05/11/2008 and displayed until 05/12/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 15/09/2008 and displayed until 05/11/2008
Reasons for adding or updating:
  • Changes to therapeutic indications
  • Change to warnings or special precautions for use
  • Change to date of revision
Updated on 08/08/2008 and displayed until 15/09/2008
Reasons for adding or updating:
  • Change to side-effects
  • Changes to therapeutic indications
Updated on 03/07/2008 and displayed until 08/08/2008
Reasons for adding or updating:
  • Improved electronic presentation
Updated on 03/07/2008 and displayed until 03/07/2008
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
  • Change to, or new use for medicine
Updated on 28/05/2008 and displayed until 03/07/2008
Reasons for adding or updating:
  • Addition of marketing authorisation holder
Updated on 15/08/2007 and displayed until 28/05/2008
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 12/07/2007 and displayed until 15/08/2007
Reasons for adding or updating:
  • Improved electronic presentation
Updated on 16/02/2007 and displayed until 12/07/2007
Reasons for adding or updating:
  • Improved electronic presentation
Updated on 17/10/2006 and displayed until 16/02/2007
Reasons for adding or updating:
  • New PIL for new product

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
  human papillomavirus vaccine